In conclusion, the presented data suggest that, only on the 7th day after a single peritumoral administration of DC-based vaccines, we can observe substantial changes in the percentage of cell CD45+ cell infiltrating tumor tissue. This evidence concerns the gene PTPRC and neoplasm.